|
1
|
Bird P, Kirkham B, Portek I, Shnier R,
Joshua F, Edmonds J and Lassere M: Documenting damage progression
in a two-year longitudinal study of rheumatoid arthritis patients
with established disease (the DAMAGE study cohort): Is there an
advantage in the use of magnetic resonance imaging as compared with
plain radiography? Arthritis Rheum. 50:1383–1389. 2004.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Døhn UM, Ejbjerg BJ, Hasselquist M,
Narvestad E, Møller J, Thomsen HS and Østergaard M: Detection of
bone erosions in rheumatoid arthritis wrist joints with magnetic
resonance imaging, computed tomography and radiography. Arthritis
Res Ther. 10(R25)2008.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
van der Woude D and van der Helm-van Mil
AHM: Update on the epidemiology, risk factors, and disease outcomes
of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 32:174–187.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ejbjerg BJ, Vestergaard A, Jacobsen S,
Thomsen HS and Østergaard M: The smallest detectable difference and
sensitivity to change of magnetic resonance imaging and
radiographic scoring of structural joint damage in rheumatoid
arthritis finger, wrist, and toe joints: A comparison of the
OMERACT rheumatoid arthritis magnetic resonance imaging score
applied to different joint combinations and the Sharp/van der
Heijde radiographic score. Arthritis Rheum. 52:2300–2306.
2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bendstrup E, Møller J, Kronborg-White S,
Prior TS and Hyldgaard C: Interstitial Lung Disease in Rheumatoid
Arthritis Remains a Challenge for Clinicians. J Clin Med.
8(E2038)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bandyopadhyay D, Banerjee U, Hajra A,
Chakraborty S, Amgai B, Ghosh RK, Haddadin FI, Modi VA, Sinha K,
Aronow WS, et al: Trends of Cardiac Complications in Patients With
Rheumatoid Arthritis: Analysis of the United States National
Inpatient Sample; 2005-2014. Curr Probl Cardiol.
46(100455)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zulfiqar AA, Niazi R, Pennaforte JL and
Andres E: Rheumatoid arthritis and cardiovascular risk factor:
Literature review. Rev Med Liege. 73:634–639. 2018.PubMed/NCBI(In French).
|
|
8
|
Atzeni F, Talotta R, Masala IF, Gerardi
MC, Casale R and Sarzi-Puttini P: Central nervous system
involvement in rheumatoid arthritis patients and the potential
implications of using biological agents. Best Pract Res Clin
Rheumatol. 32:500–510. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nakao E, Mitsunaga A, Hamano T, Shirato M,
Shirato I and Nishino T: Case report of rheumatoid arthritis
associated with type A gastritis and Hashimoto thyroiditis. Nihon
Shokakibyo Gakkai Zasshi. 107:1927–1932. 2010.PubMed/NCBI(In Japanese).
|
|
10
|
Lora V, Cerroni L and Cota C: Skin
manifestations of rheumatoid arthritis. G Ital Dermatol Venereol.
153:243–255. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kurmann RD and Mankad R: Atherosclerotic
Heart Disease in Women With Autoimmune Rheumatologic Inflammatory
Conditions. Can J Cardiol. 34:381–389. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Favalli EG, Biggioggero M, Crotti C,
Becciolini A, Raimondo MG and Meroni PL: Sex and Management of
Rheumatoid Arthritis. Clin Rev Allergy Immunol. 56:333–345.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Law ST and Taylor PC: Role of biological
agents in treatment of rheumatoid arthritis. Pharmacol Res.
150(104497)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bolon B, Stolina M, King C, Middleton S,
Gasser J, Zack D and Feige U: Rodent preclinical models for
developing novel antiarthritic molecules: Comparative biology and
preferred methods for evaluating efficacy. J Biomed Biotechnol.
2011(569068)2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hirose J and Tanaka S: Animal models for
bone and joint disease. CIA, CAIA model. Clin Calcium. 21:253–259.
2011.PubMed/NCBI(In Japanese).
|
|
16
|
Hanyecz A, Olasz K, Tarjanyi O, Nemeth P,
Mikecz K, Glant TT and Boldizsar F: Proteoglycan aggrecan
conducting T cell activation and apoptosis in a murine model of
rheumatoid arthritis. BioMed Res Int. 2014(942148)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Corrado A, Donato P, Maccari S, Cecchi R,
Spadafina T, Arcidiacono L, Tavarini S, Sammicheli C, Laera D,
Manetti AG, et al: Staphylococcus aureus-dependent septic
arthritis in murine knee joints: Local immune response and
beneficial effects of vaccination. Sci Rep. 6(38043)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Choudhary N, Bhatt LK and Prabhavalkar KS:
Experimental animal models for rheumatoid arthritis.
Immunopharmacol Immunotoxicol. 40:193–200. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Christensen AD, Haase C, Cook AD and
Hamilton JA: K/BxN Serum-Transfer Arthritis as a Model for Human
Inflammatory Arthritis. Front Immunol. 7(213)2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sønderstrup G: Development of humanized
mice as a model of inflammatory arthritis. Springer Semin
Immunopathol. 25:35–45. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nakano K, Yamaoka K, Hanami K, Saito K,
Sasaguri Y, Yanagihara N, Tanaka S, Katsuki I, Matsushita S and
Tanaka Y: Dopamine induces IL-6-dependent IL-17 production via
D1-like receptor on CD4 naive T cells and D1-like receptor
antagonist SCH-23390 inhibits cartilage destruction in a human
rheumatoid arthritis/SCID mouse chimera model. J Immunol.
186:3745–3752. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu S, Hasegawa H, Takemasa E, Suzuki Y,
Oka K, Kiyoi T, Takeda H, Ogasawara T, Sawasaki T, Yasukawa M, et
al: Efficiency and Safety of CRAC Inhibitors in Human Rheumatoid
Arthritis Xenograft Models. J Immunol. 199:1584–1595.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Williams RO: Collagen-induced arthritis in
mice. Methods Mol Med. 136:191–199. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Caplazi P, Baca M, Barck K, Carano RA,
DeVoss J, Lee WP, Bolon B and Diehl L: Mouse Models of Rheumatoid
Arthritis. Vet Pathol. 52:819–826. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cho YG, Cho ML, Min SY and Kim HY: Type II
collagen autoimmunity in a mouse model of human rheumatoid
arthritis. Autoimmun Rev. 7:65–70. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Schurgers E, Billiau A and Matthys P:
Collagen-induced arthritis as an animal model for rheumatoid
arthritis: Focus on interferon-γ. J Interferon Cytokine Res.
31:917–926. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Trentham DE, Townes AS and Kang AH:
Autoimmunity to type II collagen an experimental model of
arthritis. J Exp Med. 146:857–868. 1977.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cathcart ES, Hayes KC, Gonnerman WA,
Lazzari AA and Franzblau C: Experimental arthritis in a nonhuman
primate. I. Induction by bovine type II collagen. Lab Invest.
54:26–31. 1986.PubMed/NCBI
|
|
29
|
Courtenay JS, Dallman MJ, dayan AD, Martin
A and Mosedale B: Immunisation against heterologous type II
collagen induces arthritis in mice. Nature. 283:666–668.
1980.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Nandakumar KS: Pathogenic antibody
recognition of cartilage. Cell Tissue Res. 339:213–220.
2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wooley PH, Luthra HS, Stuart JM and David
CS: Type II collagen-induced arthritis in mice. I. Major
histocompatibility complex (I region) linkage and antibody
correlates. J Exp Med. 154:688–700. 1981.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tarkowski A, Holmdahl R and Klareskog L:
Rheumatoid factors in mice. Monogr Allergy. 26:214–229.
1989.PubMed/NCBI
|
|
33
|
Benson RA, McInnes IB, Garside P and
Brewer JM: Model answers: Rational application of murine models in
arthritis research. Eur J Immunol. 48:32–38. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Myers LK, Tang B, Rosloniec EF, Stuart JM,
Chiang TM and Kang AH: Characterization of a peptide analog of a
determinant of type II collagen that suppresses collagen-induced
arthritis. J Immunol. 161:3589–3595. 1998.PubMed/NCBI
|
|
35
|
Brand DD, Kang AH and Rosloniec EF:
Immunopathogenesis of collagen arthritis. Springer Semin
Immunopathol. 25:3–18. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Inglis JJ, Simelyte E, McCann FE, Criado G
and Williams RO: Protocol for the induction of arthritis in C57BL/6
mice. Nat Protoc. 3:612–618. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Stuart JM, Townes AS and Kang AH: Collagen
autoimmune arthritis. Annu Rev Immunol. 2:199–218. 1984.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Joe B and Wilder RL: Animal models of
rheumatoid arthritis. Mol Med Today. 5:367–369. 1999.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kannan K, Ortmann RA and Kimpel D: Animal
models of rheumatoid arthritis and their relevance to human
disease. Pathophysiology. 12:167–181. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hegen M, Keith JC Jr, Collins M and
Nickerson-Nutter CL: Utility of animal models for identification of
potential therapeutics for rheumatoid arthritis. Ann Rheum Dis.
67:1505–1515. 2008.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Petersen F and Yu X: A novel preclinical
model for rheumatoid arthritis research. Arthritis Res Ther.
12(148)2010.PubMed/NCBI View
Article : Google Scholar
|
|
42
|
Brand DD, Latham KA and Rosloniec EF:
Collagen-induced arthritis. Nat Protoc. 2:1269–1275.
2007.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Huang JC, Vestberg M, Minguela A, Holmdahl
R and Ward ES: Analysis of autoreactive T cells associated with
murine collagen-induced arthritis using peptide-MHC multimers. Int
Immunol. 16:283–293. 2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Buglak NE and Bahnson ESM: A Rat Carotid
Artery Pressure-Controlled Segmental Balloon Injury with
Periadventitial Therapeutic Application. J Vis Exp 161:
10.3791/60473, 2020.
|
|
45
|
Holmdahl R, Jansson L, Larsson E, Rubin K
and Klareskog L: Homologous type II collagen induces chronic and
progressive arthritis in mice. Arthritis Rheum. 29:106–113.
1986.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Boissier MC, Feng XZ, Carlioz A, Roudier R
and Fournier C: Experimental autoimmune arthritis in mice. I.
Homologous type II collagen is responsible for self-perpetuating
chronic polyarthritis. Ann Rheum Dis. 46:691–700. 1987.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Wilder RL: Hormones and autoimmunity:
Animal models of arthritis. Baillieres Clin Rheumatol. 10:259–271.
1996.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Vandenbroucke JP, Valkenburg HA, Boersma
JW, Cats A, Festen JJ, Huber-Bruning O and Rasker JJ: Oral
contraceptives and rheumatoid arthritis: Further evidence for a
preventive effect. Lancet. 2:839–842. 1982.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Lee YK, Choi KH, Kwak HS and Chang YH: The
preventive effects of nanopowdered red ginseng on collagen-induced
arthritic mice. Int J Food Sci Nutr. 69:308–317. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Holmdahl R, Jansson L, Gullberg D, Rubin
K, Forsberg PO and Klareskog L: Incidence of arthritis and
autoreactivity of anti-collagen antibodies after immunization of
DBA/1 mice with heterologous and autologous collagen II. Clin Exp
Immunol. 62:639–646. 1985.PubMed/NCBI
|
|
51
|
Stewart-Tull DE: Freund's complete and
incomplete adjuvants, preparation, and quality control standards
for experimental laboratory animals use. Methods Mol Biol.
626:59–72. 2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wooley PH, Luthra HS, Griffiths MM, Stuart
JM, Huse A and David CS: Type II collagen-induced arthritis in
mice. IV. Variations in immunogenetic regulation provide evidence
for multiple arthritogenic epitopes on the collagen molecule. J
Immunol. 135:2443–2451. 1985.PubMed/NCBI
|
|
53
|
Chen HH, Chen DY, Chao YH, Chen YM, Wu CL,
Lai KL, Lin CH and Lin CC: Acarbose Decreases the Rheumatoid
Arthritis Risk of Diabetic Patients and Attenuates the Incidence
and Severity of Collagen-induced Arthritis in Mice. Sci Rep.
5(18288)2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Inglis JJ, Criado G, Medghalchi M, Andrews
M, Sandison A, Feldmann M and Williams RO: Collagen-induced
arthritis in C57BL/6 mice is associated with a robust and sustained
T-cell response to type II collagen. Arthritis Res Ther.
9(R113)2007.PubMed/NCBI View
Article : Google Scholar
|
|
55
|
Liu L, Yang J, Zu B, Wang J, Sheng K, Zhao
L and Xu W: Acacetin regulated the reciprocal differentiation of
Th17 cells and Treg cells and mitigated the symptoms of
collagen-induced arthritis in mice. Scand J Immunol.
88(e12712)2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Deng Y, Luo H, Shu J, Shu H, Lu C, Zhao N,
Geng Y, He X and Lu A: Pien Tze Huang alleviate the joint
inflammation in collagen-induced arthritis mice. Chin Med.
15(30)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Luan J, Zhang K, Yang P, Zhang Y, Feng F,
Zhu YM, Zhu P and Chen ZN: The combination of FK506 and an
anti-CD147 mAb exerts potential therapeutic effects on a mouse
model of collagen-induced arthritis. Mol Immunol. 101:1–9.
2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Fu J, Zhang L, Song S, Sheng K, Li Y, Li
P, Song S, Wang Q, Chu J and Wei W: Effect of bone marrow-derived
CD11b(+)F4/80 (+) immature dendritic cells on the balance between
pro-inflammatory and anti-inflammatory cytokines in DBA/1 mice with
collagen-induced arthritis. Inflamm Res. 63:357–367.
2014.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhou X, Zhao X, Tang L, Zhang Y, Ruan H,
Pi H, Qiu J and Wu J: Immunomodulatory activity of the rhizomes of
Impatiens pritzellii var. hupehensis on collagen-induced arthritis
mice. J Ethnopharmacol. 109:505–509. 2007.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Wang Z, Zhuo F, Chu P, Yang X and Zhao G:
Germacrone alleviates collagen-induced arthritis via regulating
Th1/Th2 balance and NF-κB activation. Biochem Biophys Res Commun.
518:560–564. 2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Jia Q, Wang T, Wang X, Xu H, Liu Y, Wang
Y, Shi Q and Liang Q: Astragalin Suppresses Inflammatory Responses
and Bone Destruction in Mice With Collagen-Induced Arthritis and in
Human Fibroblast-Like Synoviocytes. Front Pharmacol.
10(94)2019.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Svetlicky N, Kivity S, Odeh Q, Shovman O,
Gertel S, Amital H, Gendelman O, Volkov A, Barshack I, Bar-Meir E,
et al: Anti-citrullinated-protein-antibody-specific intravenous
immunoglobulin attenuates collagen-induced arthritis in mice. Clin
Exp Immunol. 182:241–250. 2015.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Yang P, Qian F, Zhang M, Xu AL, Wang X,
Jiang B, Zhou L and Zhou X: Zishen Tongluo formula ameliorates
collagen-induced arthritis in mice by modulation of Th17/Treg
balance. J Ethnopharmacol. 250(112428)2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Feng ZT, Yang T, Hou XQ, Wu HY, Feng JT,
Ou BJ, Cai SJ, Li J and Mei ZG: Sinomenine mitigates
collagen-induced arthritis mice by inhibiting angiogenesis. Biomed
Pharmacother. 113(108759)2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Fan J, Luo J, Yan C, Hao R, Zhao X, Jia R,
He J, Xu D, Miao M and Li X: Methotrexate, combined with
cyclophosphamide attenuates murine collagen induced arthritis by
modulating the expression level of Breg and DCs. Mol Immunol.
90:106–117. 2017.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Wu S, Li Y, Li Y, Yao L, Lin T, Jiang S,
Shen H, Xia L and Lu J: Interleukin-35 attenuates collagen-induced
arthritis through suppression of vascular endothelial growth factor
and its receptors. Int Immunopharmacol. 34:71–77. 2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Gui H, Liu X, Liu LR, Su DF and Dai SM:
Activation of cannabinoid receptor 2 attenuates synovitis and joint
distruction in collagen-induced arthritis. Immunobiology.
220:817–822. 2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Xuzhu G, Komai-Koma M, Leung BP, Howe HS,
McSharry C, McInnes IB and Xu D: Resveratrol modulates murine
collagen-induced arthritis by inhibiting Th17 and B-cell function.
Ann Rheum Dis. 71:129–135. 2012.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Guo Y, Xing E, Song H, Feng G, Liang X, An
G, Zhao X and Wang M: Therapeutic effect of dioscin on
collagen-induced arthritis through reduction of Th1/Th2. Int
Immunopharmacol. 39:79–83. 2016.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Suszko A and Obmińska-Mrukowicz B:
Influence of polysaccharide fractions isolated from Caltha
palustris L. on the cellular immune response in
collagen-induced arthritis (CIA) in mice. A comparison with
methotrexate. J Ethnopharmacol. 145:109–117. 2013.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Bessis N, Decker P, Assier E, Semerano L
and Boissier MC: Arthritis models: Usefulness and interpretation.
Semin Immunopathol. 39:469–486. 2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Zhong C, Wang J, Li B, Xiang H, Ultsch M,
Coons M, Wong T, Chiang NY, Clark S, Clark R, et al: Development
and preclinical characterization of a humanized antibody targeting
CXCL12. Clin Cancer Res. 19:4433–4445. 2013.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Huang X, He Y, Han J, Zhuang J, He J and
Sun E: Not only anti-inflammation, etanercept abrogates
collagen-induced arthritis by inhibiting dendritic cell migration
and maturation. Cent Eur J Immunol. 44:237–245. 2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Alabarse PVG, Lora PS, Silva JMS, Santo
RCE, Freitas EC, de Oliveira MS, Almeida AS, Immig M, Teixeira VON,
Filippin LI, et al: Collagen-induced arthritis as an animal model
of rheumatoid cachexia. J Cachexia Sarcopenia Muscle. 9:603–612.
2018.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Evans WJ, Morley JE, Argilés J, Bales C,
Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H,
Mantovani G, et al: Cachexia: A new definition. Clin Nutr.
27:793–799. 2008.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Vincent TL, Williams RO, Maciewicz R,
Silman A and Garside P: Arthritis Research UK animal models working
group. Mapping pathogenesis of arthritis through small animal
models. Rheumatology (Oxford). 51:1931–1941. 2012.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Marazziti D, Ambrogi F, Abelli M, Di Nasso
E, Catena M, Massimetti G, Carlini M and Dell'Osso L: Lymphocyte
subsets, cardiovascular measures and anxiety state before and after
a professional examination. Stress. 10:93–99. 2007.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Melkus MW, Estes JD, Padgett-Thomas A,
Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT and Garcia JV:
Humanized mice mount specific adaptive and innate immune responses
to EBV and TSST-1. Nat Med. 12:1316–1322. 2006.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Akkina R: Humanized Mice for Studying
Human Immune Responses and Generating Human Monoclonal Antibodies.
Microbiol Spectr. 2:2014.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Vatakis DN, Bristol GC, Kim SG, Levin B,
Liu W, Radu CG, Kitchen SG and Zack JA: Using the BLT humanized
mouse as a stem cell based gene therapy tumor model. J Vis Exp.
70(e4181)2012.PubMed/NCBI View
Article : Google Scholar
|
